PALO ALTO, Calif., April 20, 2018 /PRNewswire/ -- Varian (NYSE:
VAR) today announced it has received FDA 510(k) clearance for its
Calypso® Anchored Beacon® transponder. Used
with a Varian TrueBeam®, Edge® and
Clinac® C-series medical linear accelerators, the
Calypso system and Anchored Beacon transponder detects even slight
movements of a tumor and helps clinicians deliver lung stereotactic
body radiotherapy (SBRT) more precisely.
The Calypso system works by implanting the Anchored Beacon
transponders in small airways within or near the tumor target. The
Anchored Beacon transponders feature five small "legs" that provide
stable fixation to prevent the transponder from moving. The
transponders emit non-ionizing electromagnetic signals that are
tracked in real-time and used to keep a treatment beam on
target.
The Calypso System is the only device on the market that
delivers real-time, continuous (25 Hz update rate), 3D tumor
position information, improving confidence that the prescribed dose
has been delivered to the tumor.
"The 510(k) clearance of the Anchored Beacon transponder expands
the application of the Calypso system platform," said Ed Vertatschitsch, vice president, Global
Portfolio Solutions, Varian. "Using the Calypso system and Anchored
Beacon transponder, clinicians can deliver dose to lung tumors with
increased confidence and accuracy."
For more information on the Calypso system, visit
www.varian.com/calypso.
About Varian
Varian is a leader in developing and delivering cancer care
solutions, and is focused on creating a world without fear of
cancer. Headquartered in Palo Alto,
California, Varian employs approximately 6,500 people around
the world. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-calypso-anchored-beacon-transponder-for-lung-receives-fda-510k-clearance-300633354.html
SOURCE Varian